U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C18H20FN3O4.H2O
Molecular Weight 740.7503
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEVOFLOXACIN

SMILES

O.C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4.C[C@H]5COC6=C7N5C=C(C(O)=O)C(=O)C7=CC(F)=C6N8CCN(C)CC8

InChI

InChIKey=SUIQUYDRLGGZOL-RCWTXCDDSA-N
InChI=1S/2C18H20FN3O4.H2O/c2*1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21;/h2*7-8,10H,3-6,9H2,1-2H3,(H,24,25);1H2/t2*10-;/m00./s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
LEVOFLOXACIN
MART.   ORANGE BOOK   USAN   USP-RS   VANDF  
USAN  
Official Name English
OFLOXACIN S-(-)-FORM HEMIHYDRATE [MI]
Common Name English
(-)-(S)-9-FLUORO-2,3-DIHYDRO-3-METHYL-10-(4-METHYL-1-PIPERAZINYL)-7-OXO-7H-PYRIDO(1,2,3-DE)-1,4-BENZOXAZINE-6-CARBOXYLIC ACID, HEMIHYDRATE
Common Name English
LEVOFLOXACIN [VANDF]
Common Name English
LEVOFLOXACIN HYDRATE [JAN]
Common Name English
LEVOFLOXACIN HYDRATE
JAN  
Common Name English
LEVOFLOXACIN [ORANGE BOOK]
Common Name English
CRAVIT
Brand Name English
LEVOFLOXACIN [USP MONOGRAPH]
Common Name English
VOLEQUIN
Brand Name English
QUINSAIR
Brand Name English
IQUIX
Brand Name English
QUIXIN
Brand Name English
LEVOFLOXACIN HEMIHYDRATE
WHO-DD  
Common Name English
LEVAQUIN
Brand Name English
RWJ-25213
Code English
TAVANIC
Brand Name English
LEVOFLOXACIN HEMIHYDRATE [EP MONOGRAPH]
Common Name English
L-OFLOXACIN
Common Name English
DR-3355
Code English
7H-PYRIDO(1,2,3-DE)-1,4-BENZOXAZINE-6-CARBOXYLIC ACID, 9-FLUORO-2,3-DIHYDRO-3-METHYL-10-(4-METHYL-1-PIPERAZINYL)-7-OXO-HYDRATE (2:1), (S)-
Common Name English
LEVOFLOXACIN (AS HEMIHYDRATE)
Common Name English
Levofloxacin hemihydrate [WHO-DD]
Common Name English
OFLOXACIN, (S)-
Common Name English
LEVOFLOXACIN [USP-RS]
Common Name English
LEVOFLOXACIN [USAN]
Common Name English
NOFAXIN
Brand Name English
LEVOFLOXACIN [MART.]
Common Name English
Classification Tree Code System Code
WHO-ATC S01AE05
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
WHO-ATC A02BD10
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
NDF-RT N0000007606
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
FDA ORPHAN DRUG 253707
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
WHO-ATC J01MA12
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
LIVERTOX NBK548357
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
NDF-RT N0000175937
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
NCI_THESAURUS C795
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
EU-Orphan Drug EU/3/08/566
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
WHO-VATC QS01AE05
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
WHO-VATC QJ01RA05
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
WHO-ATC J01RA05
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
EMA ASSESSMENT REPORTS QUINSAIR (AUTHORIZED: CYSTIC FIBROSIS)
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
WHO-VATC QJ01MA12
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C1586
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
RS_ITEM_NUM
1362103
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
FDA UNII
6GNT3Y5LMF
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
DAILYMED
6GNT3Y5LMF
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
WIKIPEDIA
LEVOFLOXACIN
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
EPA CompTox
DTXSID60160533
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
DRUG CENTRAL
1569
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
CHEBI
63598
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
USAN
II-30
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
EVMPD
SUB21640
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
CAS
138199-71-0
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
MERCK INDEX
m8133
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
SMS_ID
100000091529
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
PUBCHEM
3033924
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
LACTMED
Levofloxacin
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
DRUG BANK
DB01137
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
RXCUI
82122
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY RxNorm
ChEMBL
CHEMBL33
Created by admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
PRIMARY
SUBSTANCE RECORD
Structure of LEVOFLOXACIN
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966